BODISEN BIOTECH, INC

No description available

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

No description available

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

5.02,8.01

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

4.01

4.01,9.01

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Annual report pursuant to Section 13 or 15(d)

Correspondence with the SEC

Notification of late filing of Form 10-K

Correspondence with the SEC

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Correspondence with the SEC

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Changes in Registrant's Certifying Accountant

1.01,2.01,9.01

5.02

Other Events

2.02,9.01

4.01,8.01,9.01

4.01,9.01

Letter from the SEC

4.01,8.01

5.02

Notification of removal from listing and/or registration on a national securities exchange

Results of Operations and Financial Condition

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

3.01,8.01,9.01

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

Regulation FD Disclosure

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Definitive Proxy Statement

Letter from the SEC

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

No description available

No description available

No description available

Prospectus filed under Rule 424(b)(1)

No description available

No description available

Registration of Securities on Exchange

No description available

No description available

No description available

No description available

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Prospectus filed under Rule 424(b)(1)

Post-effective amendment to a registration statement

No description available

No description available

No description available

Guo Chenglin

Wang Lin

Yang Chuangjun

WANG QIONG

Chen Bo

Tong Junyan

Chen Bo

WAN WEIRUI

LAI YILIANG

WANG QIONG

WANG CHUNSHENG

McManus Patrick

Gatton David